British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines
| Autor: | Linda Sharp, James Docherty, Siwan Thomas-Gibson, Billie Moores, Amanda J. Cross, Kevin J. Monahan, Marco Novelli, Neil P J Cripps, Brian P. Saunders, Philip Kaye, Colin J Rees, John Marsh, Barbara Hibbert, Alison Scope, Sunil Dolwani, Matthew D. Rutter, Stewart Bonnington, Andrew Plumb, Sophie Whyte, Ruth Wong, James E. East, Damian Tolan |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Adenoma Colorectal cancer medicine.medical_treatment Colonoscopy colorectal adenomas colorectal cancer Guidelines Gastroenterology 03 medical and health sciences 0302 clinical medicine colonoscopy Internal medicine medicine Humans Postoperative Period Sigmoidoscopy Evidence-Based Medicine medicine.diagnostic_test Gastroenterology & Hepatology business.industry Public health Patient Selection Rectum 1103 Clinical Sciences medicine.disease Long-Term Care Polypectomy digestive system diseases Dysplasia colonic polyps 030220 oncology & carcinogenesis Colorectal Polyp Population Surveillance Cohort surveillance 1114 Paediatrics and Reproductive Medicine 030211 gastroenterology & hepatology Neoplasm Recurrence Local business Gastrointestinal Hemorrhage Colorectal Neoplasms |
| Zdroj: | Gut |
| ISSN: | 0017-5749 |
| Popis: | These consensus guidelines were jointly commissioned by the British Society of Gastroenterology (BSG), the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and Public Health England (PHE). They provide an evidence-based framework for the use of surveillance colonoscopy and non-colonoscopic colorectal imaging in people aged 18 years and over. They are the first guidelines that take into account the introduction of national bowel cancer screening. For the first time, they also incorporate surveillance of patients following resection of either adenomatous or serrated polyps and also post-colorectal cancer resection. They are primarily aimed at healthcare professionals, and aim to address:Which patients should commence surveillance post-polypectomy and post-cancer resection?What is the appropriate surveillance interval?When can surveillance be stopped?two or more premalignant polyps including at least one advanced colorectal polyp (defined as a serrated polyp of at least 10 mm in size or containing any grade of dysplasia, or an adenoma of at least 10 mm in size or containing high-grade dysplasia); orfive or more premalignant polypsThe Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument provided a methodological framework for the guidelines. The BSG’s guideline development process was used, which is National Institute for Health and Care Excellence (NICE) compliant.two or more premalignant polyps including at least one advanced colorectal polyp (defined as a serrated polyp of at least 10 mm in size or containing any grade of dysplasia, or an adenoma of at least 10 mm in size or containing high-grade dysplasia); orfive or more premalignant polypsThe key recommendations are that the high-risk criteria for future colorectal cancer (CRC) following polypectomy comprise either:two or more premalignant polyps including at least one advanced colorectal polyp (defined as a serrated polyp of at least 10 mm in size or containing any grade of dysplasia, or an adenoma of at least 10 mm in size or containing high-grade dysplasia); orfive or more premalignant polypsThis cohort should undergo a one-off surveillance colonoscopy at 3 years. Post-CRC resection patients should undergo a 1 year clearance colonoscopy, then a surveillance colonoscopy after 3 more years. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|